Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $124.85 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI PASTEUR INC. | $73.08 | 4 | $0 (2024) |
| Novo Nordisk Inc | $20.95 | 1 | $0 (2020) |
| Allergan Inc. | $15.76 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $15.06 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19.09 | 1 | SANOFI PASTEUR INC. ($19.09) |
| 2023 | $53.99 | 3 | SANOFI PASTEUR INC. ($53.99) |
| 2020 | $20.95 | 1 | Novo Nordisk Inc ($20.95) |
| 2019 | $15.06 | 1 | E.R. Squibb & Sons, L.L.C. ($15.06) |
| 2017 | $15.76 | 1 | Allergan Inc. ($15.76) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/21/2024 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Vaccines | ||||||
| 09/06/2023 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Vaccines | ||||||
| 05/31/2023 | SANOFI PASTEUR INC. | VAXELIS (Biological), MENQUADFI | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Vaccines | ||||||
| 01/31/2023 | SANOFI PASTEUR INC. | FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological), VAXELIS, MENQUADFI | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Vaccines | ||||||
| 09/09/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Diabetes | ||||||
| 04/05/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.06 | General |
| Category: Cardiovascular | ||||||
| 04/17/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 62 | 93 | $18,372 | $4,507 |
| 2021 | 5 | 128 | 188 | $44,016 | $10,423 |
| 2020 | 7 | 266 | 334 | $84,553 | $21,719 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 50 | $11,350 | $2,773 | 24.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 17 | 17 | $3,876 | $958.80 | 24.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 19 | 26 | $3,146 | $774.94 | 24.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 54 | 108 | $24,948 | $5,918 | 23.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 37 | 39 | $9,087 | $2,083 | 22.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 11 | 11 | $4,840 | $1,170 | 24.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 13 | 13 | $3,016 | $739.31 | 24.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 13 | 17 | $2,125 | $512.72 | 24.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 99 | 157 | $34,383 | $8,898 | 25.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 35 | 36 | $14,868 | $3,647 | 24.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 55 | 55 | $12,100 | $3,125 | 25.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 14 | 14 | $8,540 | $2,234 | 26.2% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2020 | 14 | 14 | $5,740 | $1,496 | 26.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 29 | 38 | $4,522 | $1,196 | 26.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 20 | 20 | $4,400 | $1,123 | 25.5% |
About Dr. Michael Mcgonigal, MD
Dr. Michael Mcgonigal, MD is a Surgery healthcare provider based in St. Paul, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689640963.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Mcgonigal, MD has received a total of $124.85 in payments from pharmaceutical and medical device companies, with $19.09 received in 2024. These payments were reported across 7 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($124.85).
As a Medicare-enrolled provider, Mcgonigal has provided services to 456 Medicare beneficiaries, totaling 615 services with total Medicare billing of $36,648. Data is available for 3 years (2020–2022), covering 15 distinct procedure/service records.
Practice Information
- Specialty Surgery
- Location St. Paul, MN
- Active Since 02/27/2006
- Last Updated 10/24/2023
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1689640963
Products in Payments
- Ozempic (Drug) $20.95
- VAXELIS (Biological) $19.91
- FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological) $19.09
- BEYFORTUS (Biological) $17.06
- FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological) $17.02
- NAMZARIC (Drug) $15.76
- ELIQUIS (Drug) $15.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.